72.6 F
New York
Monday, May 17, 2021

Precipio [NASDAQ: PRPO] Roll Out Rapid COVID-19 Antibody test on Amazon Platform

Must read

Oaktree [NASDAQ: OCSL] Announces Pricing of Underwritten Public Offering

Oaktree Specialty Lending Corporation disclosed that it has set the price of an underwritten public offering of $350.0 million aggregate principal amount of...

Black.one Introduces Cryptocurrency Exchange Venture with $10B in Funding

Black.one has disclosed Tuesday that it has launched Bullish Global. Bullish Global is a subsidiary of Black.one. It is a new blockchain-based cryptocurrency exchange...

Pfizer-BioNTech COVID-19 Vaccine Gets FA Approval for Emergency Use in Adolescents

Pfizer Inc. and BioNTech SE disclosed that its COVID-19 vaccine has got the FDA approval for its COVID-19 vaccine. After the approval,...

Soliton [NASDAQ: SOLY] to be Acquired by Allergan Aesthetics

Soliton, Inc. disclosed Monday that it has inked an agreement with Allergen Aesthetics. As per the agreement, Allergen Aesthetics will buy Soliton. Allergen...

Shares of Precipio, Inc. [NASDAQ: PRPO] skyrocketed 40.35% during the trading session of Monday. The strong performance of the firm has highlighted the positive sentiments of the investors after the firm disclosed that it has successfully rolled out its COVID-19 rapid antibody test.

The rapid antibody test of the firm tests for both IgG & IgM antibodies, on the business platform of Amazon.com. Furthermore, Precipio possessed special rights to disseminate this product on the platform of Amazon.

Shares of Precipio soared 41.76% as it gained +0.83 during the tarding session of the firm. The firm has reported the tarding volume of 38.44 million as compared to the average volume of 605.95K. PRPO has total market capitalization of $34.31 million at the time of writing.

COVID-19 Rapid Antibody Test 

The antibody test is the 20-minute test. It is built in the USA by Nirmidas Biotech, of California. It is the first US-based test to get EUA by the FDA for point-of-care. Furthermore, it has been disclosed that this product is accessible to people on Amazon’s website.

Purpose of  COVID-19 Antibody Test

The main purpose of the COVID-19 antibody test is to identify whether the person develop antibodies or not after the person has been exposed to the virus, or has been vaccinated.

Additionally, this antibody has two main benefits. Firstly, the person will be able to know whether he has antibodies or not. Lastly, individuals who have been vaccinated will be able to know whether the vaccination was successful. Moreover, they will be able to know if the antibodies measured have persisted over time.

More articles

Latest article

Elon Musk’s SpaceX to Roll Out Dogecoin-Backed Satellite to the Moon in 2022

Elon Musk’s SpaceX has decided to recognize Dogecoin as payment to roll out its “DOGE-1 Mission to the Moon”. The mission is going to...

SBI CEO Yoshitaka Kitao Reveals Ripple to Go Public after its Legal Battle with the SEC is Over

CEO of Japanese financial services company SBI Holdings, Yoshitaka Kitao disclosed that Ripple has opted for an option to go public once its legal...

Coinbase Pro Announces it will be Listing Internet Computer’s ICP

Coinbase Pro cryptocurrency exchange has disclosed that it has decided to list ICP once it goes live. ICP is the governance token of the...

WISeKey [NASDAQ: WKEY] Gets Investment to finance its TrustNFT.IO NFT Platform

WISeKey International Holding AG disclosed Friday that it has inked a term-sheet to enter into an unsecured short-term loan and the issuance and...

Moderna [NASDAQ: MRNA] Inks Supply Agreement with Switzerland

Moderna, Inc. disclosed that it has inked a supply agreement on Thursday with the Swiss Federal Government. As per the agreement, Moderna Inc...

TeraBlock Will Have its Own BSCPad IDO Soon

TeraBlock which is a project making a platform for automated cryptocurrency portfolio management disclosed that it is preparing for an initial DEX offering (IDO)...

Why Chiasma [NASDAQ: CHMA] Stock is Skyrocketed?

Shares of Chiasma, Inc. surged 46.48% during the trading session of Wednesday. Chiasma has disclosed the financial results for the Q1 completed March...

NeoGenomics [NASDAQ: NEO] Announces Acquisition of Inivata Ltd

NeoGenomics, Inc. revealed Wednesday that it has decided to purchase Inivata Ltd. Inivata will grow into a liquid biopsy-centered division together with increasing...